Back
Zevra Therapeutics Stock Price Chart
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Sell
49
ZVRA
Zevra Therapeutics
Last Price:
$9.37
Seasonality Move:
37.31%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.
Zevra Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.95 | Buy |
| 20-day SMA: | 8.67 | Buy |
| 50-day SMA: | 7.84 | Buy |
| 200-day SMA: | 8.04 | Buy |
| 8-day EMA: | 9 | Buy |
| 20-day EMA: | 8.65 | Buy |
| 50-day EMA: | 8.21 | Buy |
| 200-day EMA: | 7.7 | Buy |
Zevra Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 67.85 | Buy |
| Chaikin Money Flow: | 154835 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.96 - 8.98) | Buy |
| Bollinger Bands (100): | (7.3 - 8.44) | Buy |
Zevra Therapeutics Technical Analysis
| May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 9.28 while ZVRA 8-day simple moving average is 8.95, which is a Buy signal.
-
The stock price of ZVRA is 9.28 while Zevra Therapeutics 20-day SMA is 8.67, which makes it a Buy.
-
Zevra Therapeutics 50-day simple moving average is 7.84 while ZVRA share price is 9.28, making it a Buy technically.
-
ZVRA stock price is 9.28 and Zevra Therapeutics 200-day simple moving average is 8.04, creating a Buy signal.
ZVRA Technical Analysis vs Fundamental Analysis
Sell
49
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a SellThe current Zevra Therapeutics [ZVRA] share price is $9.28. The Score for ZVRA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
507.4M
Price in USD:
9.28
Share Volume:
636.5K
Zevra Therapeutics 52-Week Range
52-Week High:
9.76
52-Week Low:
4.20
Sell
49
Zevra Therapeutics (ZVRA)
is a Sell
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?The Zevra Therapeutics stock price is 9.28 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is overvalued.
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 9.28 while ZVRA 8-day exponential moving average is 9.00, which is a Buy signal.
-
The stock price of ZVRA is 9.28 while Zevra Therapeutics 20-day EMA is 8.65, which makes it a Buy.
-
Zevra Therapeutics 50-day exponential moving average is 8.21 while ZVRA share price is 9.28, making it a Buy technically.
-
ZVRA stock price is 9.28 and Zevra Therapeutics 200-day simple moving average is 7.70, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.20 per share, an increase this year of $3.02 per share, and a decrease next year of $0.45 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is 0.36, suggesting Zevra Therapeutics is a Buy
-
Zevra Therapeutics Relative Strength Index (RSI) is 67.85, which suggest Zevra Therapeutics is overbought
-
The Bollinger Bands (25) for Zevra Therapeutics is (7.96 - 8.98), which suggest Zevra Therapeutics is a Buy
-
The Bollinger Bands (100) for Zevra Therapeutics is (7.3 - 8.44), which suggest Zevra Therapeutics is a Buy
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.